FASCINATION ABOUT RO5256390

quinupristin/dalfopristin will enhance the amount or outcome of avanafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. CYP3A4 inhibitors may perhaps cut down avanafil clearance expanding systemic publicity to avanafil; enhanced stages may bring about enhanced related adverse activities; the maximum proposed dose of ST